WuXi PharmaTech Ranks 27th on Deloitte Technology Fast 50 China
Nov 28, 2006
November 28, 2006 - Shanghai, China - WuXi PharmaTech, China's leading drug R&D service company, announced today it has been chosen in the "Deloitte Technology Fast 50 China 2006", a ranking of the 50 fastest growing technology companies in China, for the second consecutive year. Selection for the prestigious award is based on a company's average rate of growth over past three years.
"We are honored to have our success once again recognized by Deloitte." said Mr. Benson Tsang, Chief Financial Officer of WuXi PharmaTech. "In 2006 WuXi PharmaTech expanded its physical structure and service capability. I am as well pleased to see an increased quantity of new recipients of the award this year, while at the same time the standards for qualification are becoming increasingly stringent. Facing a new set of challenges and growth opportunities in the coming year, WuXi PharmaTech will continuously evolve its services and solutions to ever changing industry and customer needs," continued Mr. Tsang.
The 50 winning companies come from 10 cities/regions in the North, East, South and Northeast of China, 28 of them are repeat winners. This year's biotech/ pharmaceutical representation increased to 6%.
About WuXi PharmaTech (Cayman) Inc.
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.